Shareholder Alert: Ademi LLP investigates whether Immunome, Inc. has obtained a Fair Price in its Private Placement and its transaction with Morphimmune

MILWAUKEE, June 30, 2023 /PRNewswire/ — Ademi LLP is investigating Immunome (Nasdaq: IMNM) for possible breaches of fiduciary duty and other violations of law in its private placement and its transaction with Morphimmune. Click here to learn how to join the action…